BiotechTube
Home/Bioxodes/Marc Dechamps
MD

Marc Dechamps

Chief Executive Officer

Bioxodes

Therapeutic Areas

StrokeThrombo-inflammatory DiseasesNeuroinflammation

Bioxodes Pipeline

DrugIndicationPhase
BIOX-101 (Ir-CPI)Intracerebral Hemorrhage (ICH)Phase 2b (preparing)
Pipeline candidatesChronic Thrombo-inflammatory & Inflammatory DiseasesDiscovery/Pre-clinical

Leadership Team at Bioxodes

PM
Philippe Monteyne
Chairman of the Board
View full Bioxodes profile